Loading…
This event has ended. Create your own event on Sched.
Friday, March 15 • 7:00am - 5:00pm
PO090: Preclinical Evaluation Of NCX 4251, A Novel Steroid Therapy For Blepharitis, Targeted Directly To The Eyelid Margin To Reduce The Potential For IOP Elevations

Sign up or log in to save this to your schedule and see who's attending!



Friday March 15, 2019 7:00am - 5:00pm
Atrium – Second Floor San Francisco Marriott Marquis